RMD - ResMed Non-GAAP EPS of $1.60 misses by $0.09 revenue of $1.12B misses by $20M
2023-08-03 16:39:25 ET
- ResMed press release ( NYSE: RMD ): Q4 Non-GAAP EPS of $1.60 misses by $0.09 .
- Revenue of $1.12B (+22.4% Y/Y) misses by $20M .
- Operating cash flow of $237.4 million.
- Gross margin contracted 210 bps to 55.0%; non-GAAP gross margin contracted 200 bps to 55.8%.
For further details see:
ResMed Non-GAAP EPS of $1.60 misses by $0.09, revenue of $1.12B misses by $20M